B. Maddux

Molecular Biology · 2002–2003

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom B. Maddux trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Jump (in Cancer Research)

Who trusts B. Maddux

  1. P. Havel (in Physiology)

Papers from B. Maddux's perspective

Ordered by how strongly the researchers B. Maddux trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (Nature)
  2. Molecular motors
  3. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. (Proceedings of the National Academy of Sciences of the United States of America)
  4. Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ (Science)
  5. Prevention of fat-induced insulin resistance by salicylate. (Journal of Clinical Investigation)
  6. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. (Diabetes)
  7. Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* (Journal of Biological Chemistry)
  8. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. (New England Journal of Medicine)
  9. Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A* (Journal of Biological Chemistry)
  10. Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity. (Endocrinology)

Their papers